Abstract
It is not known whether the apolipoprotein E (ApoE) ε4 allelic variant is associated with human immunodeficiency virus (HIV)-associated dementia (HAD) in a South African population, where HIV clade C is predominant. ApoE genotyping was performed on 144 participants in a larger study of HIV-associated neurocognitive disorders (HAND). There was a lower frequency of the ε2 and ε3 alleles in the HIV-positive group, compared to a group of 300 community-based newborn infants. There were no differences in ApoE genotype across different categories of HAND. The ε4 allelic variant was less common in individuals with HAD than in those without HAD. These findings suggest that the ε4 allelic variant in HIV-positive individuals is not associated with the development of HAD in Southern Africa.
Similar content being viewed by others
References
An SF, Giometto B, Groves M, Miller RF, Beckett AA, Gray F, Tavolato B, Scaravilli F (1997). Axonal damage revealed by accumulation of beta-APP in HIV-positive individuals without AIDS.J Neuropathol Exp Neurol 56: 1262–1268.
Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007). Updated research nosology for HIV-associated neurocognitive disorders.Neurology 69: 1789–1799.
Barger SW, Harmon AD (1997). Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E.Nature 388: 878–881.
Mold JE, Cavrois M, Huang Y, Mahley RW, Dolan MJ, McCune JM, Ahuja SK (2008). Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression.Proc Natl Acad Sci U S A 105: 8718–8723.
Colton CA, Needham LK, Brown C, Cook D, Rasheed K, Burke JR, Strittmatter WJ, Schmechel DE, Vitek MP (2004). APOE genotype-specific differences in human and mouse macrophage nitric oxide production.J Neuroimmunol 147: 62–67.
Corder EH, Paganelli R, Giunta S, Franceschi C (2008). Differential course of HIV-1 infection and APOE polymorphism.Proc Natl Acad Sci U S A 105: E87.
Corder EH, Robertson K, Lannfelt L, Bogdanovic N, Eggertsen G, Wilkins J, Hall C (1998). HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy.Nat Med 4: 1182–1184.
Department of Health (2008). South Africa National HIV and Syphilis Prevalence Survey. Pretoria, South Africa: Department of Health.
Dunlop O, Goplen AK, Liestol K, Myrvang B, Rootwelt H, Christophersen B, Kvittingen EA, Maehlen J (1997). HIV dementia and apolipoprotein E.Acta Neurol Scand 95: 315–318.
Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC (2002c). Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review.Am J Epidemiol 155: 487–495.
Esiri MM, Biddolph SC, Morris CS (1998). Prevalence of Alzheimer plaques in AIDS.J Neurol Neurosurg Psychiatry 65: 29–33.
Fernhaber C, Reyneke A, Schulze D, Malope B, Maskew M, Macphail P, Sanne I, Di Biscleglie A (2008). The prevalence of hepatitis B co-infection in a South African urban government HIV clinic.S Afr Med J 98: 541–544.
Frisoni GB, Geroldi C, Bianchetti A, Trabucchi M, Govoni S, Franceschini G, Calabresi L (1994). Apolipoprotein E epsilon 4 allele frequency in vascular dementia and Alzheimer’s disease.Stroke 25: 1703–1704.
Gerdes LU (2003). The common polymorphism of apolipoprotein E: geographical aspects and new pathophysiological relations.Clin Chem Lab Med 41: 628–631.
Gupta JD, Satishchandra P, Gopukumar K, Wilkie F, Waldrop-Valverde D, Ellis R, Ownby R, Subbakrishna D. K, Desai A, Kamat A, Ravi V, Rao BS, Satish KS, Kumar M (2007). Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India.J. NeuroVirol 13: 195–202.
Hixson JE. Vernier, DT (1990). Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.J Lipid Res 31: 545–548.
Jacobs GB, Loxton AG, Laten A, Robson B, van Rensburg EJ, Engelbrecht S (2009). Emergence and diversity of different HIV-1 subtypes in South Africa, 2000–2001.J Med Virol 81: 1852–1859.
Joska JA, Fincham DS, Stein DJ, Paul RH, Seedat S (2009). Clinical correlates of HIV-associated neurocognitive disorders in South Africa.AIDS Behav 14(2): 371–378.
Joska JA, Westgarth-Taylor J, Myer L, Hoare J, Thomas KG, Combrinck M, Paul RH, Stein DJ, Flisher AJ (2010). Characterization of HIV-associated neurocognitive disorders among individuals starting antiretroviral therapy in South Africa.AIDS Behav [Epub ahead of print]
Kamboh MI, Sepehrnia B, Ferrell RE (1989). Genetic studies of human apolipoproteins. VI. Common polymorphism of apolipoprotein E in blacks.Dis Markers 7: 49–55.
Kaslow RA, Dorak T, Tang JJ (2005). Influence of host genetic variation on susceptibility to HIV type 1 infection.J Infect Dis 191(Suppl 1): S68-S77.
Laws SM, Hone E, Gandy S, Martins RN (2003). Expanding the association between the APOE gene and the risk of Alzheimer’s disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription.J Neurochem 84: 1215–1236.
Mahley RW, Weisgraber KH, Huang Y (2009). Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer’s disease to AIDS.J Lipid Res 50(Suppl): S183-S188.
Mayo O (2008). A century of Hardy-Weinberg equilibrium.Twin Res Hum Genet 11: 249–256.
Mishra M, Vetrivel S, Siddappa N. B, Ranga U, Seth P (2008). Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif.Ann Neurol 63: 366–376.
Pemberton LA, Stone E, Price P, van BF, Brew BJ (2008). The relationship between ApoE, TNFA, IL1a, IL1b and IL12b genes and HIV-1-associated dementia.HIV Med 9: 677–680.
Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A, Niinisto L, Halonen P, Kontula K (1995). Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein.N Engl J Med 333: 1242–1247.
Samatovicz RA (2000). Genetics and brain injury: apolipoprotein E.J Head Trauma Rehabil 15: 869–874.
Sandholzer C, Delport R, Vermaak H, Utermann G (1995). High frequency of the apo epsilon 4 allele in Khoi San from South Africa.Hum Genet 95: 46–48.
Valcour V, Shikuma C, Shiramizu B, Watters M, Poff P, Selnes OA, Grove J, Liu Y, bdul-Majid KB, Gartner S, Sacktor N (2004). Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort.J Neuroimmunol 157: 197–202.
Valcour V, Shiramizu B, Shikuma C (2008). Frequency of apolipoprotein E4 among older compared with younger HIV patients: support for detrimental effect of E4 on survival.Proc Natl Acad Sci U S A 105: E66-E68.
Author information
Authors and Affiliations
Corresponding author
Additional information
J.J. has received support from the National Research Foundation, the Biological Psychiatry Special Interest Group of the South Africa Society of Psychiatrists, the Medical Research Foundation of South Africa, and the Faculty of Health Sciences Research Committee, University of Cape Town. M.C. has received support from the National Research Foundation of South Africa. D.J.S. has received research grants and/or consultancy honoraria from Astrazeneca, Eli-Lilly, Glaxosmithkline, Lundbeck, Orion, Pfizer, Pharmacia, Roche, Servier, Solvay, Sumitomo, and Wyeth. The authors wish to thank the following research staff: Jean Luyt, Dr. Tricia Owen, Dorothy Magwaxaza, Lorraine Adendorff, and Judy Xala. The authors also thank the research participants for their time and willingness to take part.
This paper was first published online on Early Online on 8 September 2010.
Rights and permissions
About this article
Cite this article
Joska, J.A., Combrinck, M., Valcour, V.G. et al. Association between apolipoprotein E4 genotype and human immunodeficiency virus-associated dementia in younger adults starting antiretroviral therapy in South Africa. Journal of NeuroVirology 16, 377–383 (2010). https://doi.org/10.3109/13550284.2010.513365
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.3109/13550284.2010.513365